唐奈康配方通过调节SHIP2/PI3K/AKT通路来缓解糖尿病病中的细胞损伤
Tao Yang1,2, Yongxin Huang2, Wenjing Li2
1Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, China.
Journal of diabetes research
|November 28, 2025
概括
唐奈康 (TNK) 通过改善功能和减少细胞损伤,保护糖尿病病 (DN). 它在小鼠模型和细胞培养中调节SHIP2/PI3K/AKT通路.
科学领域:
- 药理学 药理学是指药理学的学科.
- 腎臟病學 (nephrology) 是一種醫學.
- 传统中国医药 传统中国医药
背景情况:
- 糖尿病病 (DN) 是糖尿病的一种主要并发症,其特征是细胞损伤.
- 传统中医 (TCM) 配方正在探索在管理DN的潜在治疗益处.
- 唐奈康 (TNK) 是一种TCM配方,研究其对DN的保护作用.
研究的目的:
- 调查TangNaikang (TNK) 在减轻糖尿病脏病 (DN) 中的 podocyte 损伤中的保护机制.
- 使用体内和体外模型阐明TNK治疗效果所涉及的分子途径.
主要方法:
- 使用UPLC-Q-TOF/MS.识别了TNK和含有TNK的血清的化学成分.
- 网络药理学被用来分析TNK在治疗DN的机制.
- db/db小鼠和高葡萄糖诱导的MPC5细胞被用作实验模型,以评估TNK对功能,组织病理和与细胞损伤和PI3K/AKT通路相关的蛋白质表达的影响.
主要成果:
- TNK由69种化合物组成,含有TNK的血清含有34种已识别的化合物.
- 在db/db小鼠中,TNK治疗显著改善了血清脂质概况和脏结构/功能.
- TNK调节了细胞关联蛋白 (SYNPO,nephrin,CD2AP,podocin) 和PI3K/AKT通路蛋白 (PI3K,AKT,SHIP2,IRS2,GLUT4) 在脏组织和MPC5细胞中的表达.
结论:
- 唐纳康 (TNK) 改善了糖尿病脏病 (DN) 和高葡萄糖诱导的细胞损伤中的细胞损伤.
- 通过调节SHIP2/PI3K/AKT信号通路来调节TNK的保护作用.
更多相关视频
08:15Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
897
10:31Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
581
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
5.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.3K
The JAK-STAT Signaling Pathway
11.8K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
11.8K
